CCRM
Brian Bradshaw is an accomplished scientist with extensive experience in developmental and stem cell biology. Currently serving as Lead Scientist II on the Advance Team at CCRM since January 2022, Brian previously held the position of Lead Scientist I on the same team. Prior to joining CCRM, Brian was a Postdoctoral Research Fellow at The Hospital for Sick Children from March 2017 to December 2021, and at the National University of Ireland, Galway from February 2015 to April 2016, focusing on regeneration and stem cell biology. Brian holds a Doctor of Philosophy (PhD) in Zoology/Molecular Biology from the University of Galway, earned between 2010 and 2014, and a Bachelor’s degree in Zoology and Molecular Biology from the same institution, completed in 2010.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.